1887
  1. Home
  2. Eurosurveillance
  3. Volume 24, Issue 45, 07/Nov/2019
  4. Article
Rapid communication Open Access
Like 0
Download

Abstract

On 1 October 2019, a locally-acquired Zika virus disease case was laboratory confirmed in Hyères, Var department. Active case finding identified two additional locally-acquired cases living within 90 m, with symptom onset 8 days before the index case. Extensive patient interviews did not yield information supporting transmission through sexual contact or substances of human origin. Vector-borne transmission by local mosquitoes is the most likely mode of transmission. Here we describe the public health response.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2019.24.45.1900655
2019-11-07
2024-04-20
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2019.24.45.1900655
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/24/45/eurosurv-24-45-1.html?itemId=/content/10.2807/1560-7917.ES.2019.24.45.1900655&mimeType=html&fmt=ahah

References

  1. Musso D, Ko AI, Baud D. Zika Virus Infection - After the Pandemic. N Engl J Med. 2019;381(15):1444-57.  https://doi.org/10.1056/NEJMra1808246  PMID: 31597021 
  2. Agence Régionale de Santé PACA Délégation départementale du Var. Plan de lutte contre la propagation des maladies vectorielles transmises par Aedes albopictus: chikungunya, dengue et Zika dans le département du Var pour 2018. RAA N°20 spécial du 6 avril 2018. [Response plan against the spread of vector-borne diseases transmitted by Aedes albopictus: chikungunya, dengue and Zika, Var department, 2018. RAA N° 20 special on 6 April 2018]. Toulon: Agence Régionale de Santé PACA, délégation départementale du Var; 3 Apr 2019. French. Available from: https://www.paca.ars.sante.fr/system/files/2018-09/APLAV18_83_ars_paca_1.pdf
  3. Hoen B, Schaub B, Funk AL, Ardillon V, Boullard M, Cabié A, et al. Pregnancy outcomes after ZIKV infection in French territories in the Americas. N Engl J Med. 2018;378(11):985-94.  https://doi.org/10.1056/NEJMoa1709481  PMID: 29539287 
  4. Pomar L, Vouga M, Lambert V, Pomar C, Hcini N, Jolivet A, et al. Maternal-fetal transmission and adverse perinatal outcomes in pregnant women infected with Zika virus: prospective cohort study in French Guiana. BMJ. 2018;363:k4431.  https://doi.org/10.1136/bmj.k4431  PMID: 30381296 
  5. Musso D, Stramer SL, Busch MPAABB Transfusion-Transmitted Diseases CommitteeInternational Society of Blood Transfusion Working Party on Transfusion-Transmitted Infectious Diseases. Zika virus: a new challenge for blood transfusion. Lancet. 2016;387(10032):1993-4.  https://doi.org/10.1016/S0140-6736(16)30428-7  PMID: 27156435 
  6. Counotte MJ, Kim CR, Wang J, Bernstein K, Deal CD, Broutet NJN, et al. Sexual transmission of Zika virus and other flaviviruses: A living systematic review. PLoS Med. 2018;15(7):e1002611.  https://doi.org/10.1371/journal.pmed.1002611  PMID: 30040845 
  7. Entente interdépartementale pour la démoustication du littoral méditerranéen (EID Méditerranée). En Provence-Alpes-Côte-d'Azur. [In Provence-Alpes-Côte-d’Azur]. Montpellier: Méditerranée EID; 2013. [Accessed 6 Nov 2019]. French. Available from: http://albopictus83.org/index.php/une-competence-du-cg/129-en-provence-alpes-cote-dazur
  8. European Centre for Disease Prevention and Control (ECDC). Factsheet about Zika virus disease. Stockholm: ECDC; 2016. [Accessed 11 Oct 2019]. Available from: https://www.ecdc.europa.eu/en/zika-virus-infection/facts/factsheet
  9. Mier-y-Teran-Romero L, Delorey MJ, Sejvar JJ, Johansson MA. Guillain-Barré syndrome risk among individuals infected with Zika virus: a multi-country assessment. BMC Med. 2018;16(1):67.  https://doi.org/10.1186/s12916-018-1052-4  PMID: 29759069 
  10. McKenzie BA, Wilson AE, Zohdy S. Aedes albopictus is a competent vector of Zika virus: A meta-analysis. PLoS One. 2019;14(5):e0216794.  https://doi.org/10.1371/journal.pone.0216794  PMID: 31112569 
  11. Jupille H, Seixas G, Mousson L, Sousa CA, Failloux A-B. Zika Virus, a New Threat for Europe? PLoS Negl Trop Dis. 2016;10(8):e0004901.  https://doi.org/10.1371/journal.pntd.0004901  PMID: 27505002 
  12. Heitmann A, Jansen S, Lühken R, Leggewie M, Badusche M, Pluskota B, et al. Experimental transmission of Zika virus by mosquitoes from central Europe. Euro Surveill. 2017;22(2):30437.  https://doi.org/10.2807/1560-7917.ES.2017.22.2.30437  PMID: 28106528 
  13. Grard G, Caron M, Mombo IM, Nkoghe D, Mboui Ondo S, Jiolle D, et al. Zika virus in Gabon (Central Africa)--2007: a new threat from Aedes albopictus? PLoS Negl Trop Dis. 2014;8(2):e2681.  https://doi.org/10.1371/journal.pntd.0002681  PMID: 24516683 
  14. Pan American Health Organization/World Health Organization (PAHO/WHO). Zika - Epidemiological Update, 21 April 2016. Washington: PAHO/WHO; 2016. Available from: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=34243&lang=en
  15. Spiteri G, Sudre B, Septfons A, Beauté JThe European Zika Surveillance Network. Surveillance of Zika virus infection in the EU/EEA, June 2015 to January 2017. Euro Surveill. 2017;22(41):17-00254.  https://doi.org/10.2807/1560-7917.ES.2017.22.41.17-00254  PMID: 29043960 
  16. European Centre for Disease Prevention and Control (ECDC). Rapid risk assessment: Zika virus transmission worldwide. Stockholm: ECDC; 9 Apr 2019. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/zika-risk-assessment-9-april-2019.pdf
  17. European Centre for Disease Prevention and Control (ECDC). Rapid risk assessment: Zika virus disease in Var department, France. ECDC: Stockholm; 16 Oct 2019. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-Zika-France-16-Oct-2019-corrected.pdf
  18. World Health Organization (WHO). Disease outbreak news. Zika virus disease – France. Geneva: WHO; 1 Nov 2019. [Accessed 6 Nov 2019]. Available from: https://www.who.int/csr/don/01-november-2019-zika-virus-disease-france/en/
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error